IAS Inflammation Academy

Overview

The International Atherosclerosis Society Inflammation Academy aims to identify and develop promising early career researchers and physicians who have the capacity to become the next generation of key opinion leaders on the topic of inflammation in cardiometabolic disease.

The first activity will be an in-person session, providing intensive face-to-face instruction to fellows and setting the stage for the year ahead. The in-person session will take place on August 28, 2025 from 1pm – 7:30pm in Madrid, Spain. Faculty and attendees will come together for six hours, allowing time for introductions, instruction and discussion; and conclude with a networking reception.

Course and Faculty

IAS’ Immediate Past President Peter Libby, MD, will serve as the course director, and will be supported by the following international faculty:

• Cristina Izar, MD, PhD
• Wolfgang Koenig, MD
• Samia Mora, MD, MHS
• Jessica Peña, MD, MPH

The full program can be viewed here.

Academy Activities

The session in Madrid is just the beginning of the yearlong program.

Over the next year, IAS will host a series of interactive webinars open to the society’s global membership that focus on current issues or controversies related to inflammation to keep attendees engaged and abreast of the latest research findings and recommendations for optimal management of patients. Examples of topics include late-breaking clinical findings, hot topic publications, and expert speakers about emerging basic and clinical science. Participants themselves will work with course faculty to develop webinar content, providing them with an opportunity to contribute and develop leadership skills on the topic, foster the growth of mentor-mentee relationships, and present to IAS’ global audience.

Fellows will also receive training on how to author thought leadership content and will pen their own blog posts, which will be released via the IAS LinkedIn account throughout the next year.

Fellows

From a competitive global application process, IAS selected 30 attendees from 25 countries to participate in the inaugural cohort. IAS is pleased to introduce these early career researchers and physicians.

The IAS Inflammation Academy is supported with an unrestricted grant from Novo Nordisk. All program content remains fully under control of IAS.